Drugmakers Must Face Warranty Claims In Valsartan MDL

By Bill Wichert · January 25, 2021, 4:06 PM EST

A New Jersey federal judge has said manufacturers, wholesalers and pharmacies cannot escape warranty claims in multidistrict litigation alleging they took part in distributing generic drugs containing the active ingredient valsartan...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION

Case Number

1:19-md-02875

Court

New Jersey

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Date Filed

February 14, 2019